Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New hypolipidemic agents described by Nippon Zoki

Nov. 15, 1996

ADIR claims new agents for treating bone resorption

Nov. 15, 1996

Unprecedented efficacy and safety reported for Crinone in gynecological disorders

Nov. 8, 1996

MRC to coordinate large, long-term trial of HRT

Nov. 8, 1996

Third submission for Muse

Nov. 8, 1996

Treatment guidelines for erectile dysfunction

Nov. 8, 1996

Little time devoted to treating male infertility in U.S.

Nov. 8, 1996

Scotia clarifies questions regarding its PLA dossier for Tarabetic

Nov. 8, 1996

Novo Nordisk/Takeda diabetes collaboration

Nov. 8, 1996

Phase IIb/IIc trials with CholestaGel

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...